United Therapeutics CEO trust sells 9,500 shares
After the exercise, the reported option position was 337,910 options; separate entries listed 40,513 directly held common shares and 166 shares held by Rothblatt’s spouse.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
United Therapeutics Corporation (UTHR) Chairperson & CEO Martine A. Rothblatt reported that stock options held in a family trust were exercised for 9,500 common shares at an exercise price of $117.76 per share on September 29, 2026; 9,500 trust-held common shares were sold that day in multiple transactions.
The exercise and sales were pursuant to a pre-arranged 10b5-1 trading plan Rothblatt adopted on November 7, 2025. The plan will continue until the earlier of exercise of 1,734,410 stock options, all of which expire on March 15, 2027, or December 31, 2026.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.42M approx. pre-tax spread)
Exercise and Sale
19 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($4.54M)
Approx. gross sale proceeds
$4.54M
Approx. exercise cost
$1.12M
Approx. pre-tax spread
$3.42M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F17, F18 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $117.76 | $1.12M |
| Sale | Common Stock F1, F3, F2 | 400 | $472.0452 | $189K |
| Sale | Common Stock F1, F4, F2 | 449 | $472.9682 | $212K |
| Sale | Common Stock F1, F5, F2 | 80 | $473.8553 | $38K |
| Sale | Common Stock F1, F6, F2 | 552 | $475.115 | $262K |
| Sale | Common Stock F1, F7, F2 | 1,395 | $476.1005 | $664K |
| Sale | Common Stock F1, F8, F2 | 2,135 | $477.087 | $1.02M |
| Sale | Common Stock F1, F9, F2 | 2,309 | $478.0956 | $1.10M |
| Sale | Common Stock F1, F10, F2 | 1,200 | $479.0745 | $575K |
| Sale | Common Stock F1, F2 | 160 | $479.59 | $77K |
| Sale | Common Stock F1, F11, F2 | 500 | $481.2241 | $241K |
| Sale | Common Stock F1, F12, F2 | 120 | $482.2806 | $58K |
| Sale | Common Stock F1, F13, F2 | 200 | $486.77 | $97K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F14 | -- | -- | -- |
| holding | Common Stock F15 | -- | -- | -- |
| holding | Common Stock F16 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 337,910 contracts (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (18)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. This transaction was executed in multiple trades at prices ranging from $478.58 to $479.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $480.88 to $481.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $481.88 to $482.555. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $486.75 to $486.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F15. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F16. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17. These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F18. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $471.51 to $472.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $472.53 to $473.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $473.54 to $474.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $474.56 to $475.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $475.58 to $476.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $476.58 to $477.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $477.58 to $478.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Stock options exercised: 9,500 options
Exercise price: $117.76 per share
Common shares sold: 9,500 shares
+4 more
7 metrics
Stock options exercised
9,500 options
September 29, 2026
Exercise price
$117.76 per share
Options exercised on September 29, 2026
Common shares sold
9,500 shares
September 29, 2026
Reported option position after exercise
337,910 options
Following the September 29, 2026 transaction
Direct common-stock holdings
40,513 shares
Reported on September 29, 2026
Spouse-held common-stock holdings
166 shares
Reported on September 29, 2026
Plan exercise threshold
1,734,410 stock options
The plan continues until the earlier of this exercise threshold or December 31, 2026
Key Terms
pre-arranged 10b5-1 trading plan, weighted average price, exercise price
3 terms
pre-arranged 10b5-1 trading plan regulatory
"pursuant to a pre-arranged 10b5-1 trading plan"
weighted average price financial
"reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
exercise price financial
"stock options at an exercise price of $117.76 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many UTHR stock options did Martine A. Rothblatt’s family trust exercise?
The family trust exercised 9,500 stock options for common shares on September 29, 2026, at an exercise price of $117.76 per share.
What were the terms of Martine A. Rothblatt’s UTHR trading plan?
The pre-arranged plan Rothblatt adopted on November 7, 2025, will continue until the earlier of exercise of 1,734,410 stock options, all of which expire on March 15, 2027, or December 31, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
